A
Arjan Vissink
Researcher at University Medical Center Groningen
Publications - 723
Citations - 26547
Arjan Vissink is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Implant & Medicine. The author has an hindex of 78, co-authored 668 publications receiving 22780 citations. Previous affiliations of Arjan Vissink include Lund University & University of Groningen.
Papers
More filters
Journal ArticleDOI
Periodontitis prevalence and severity in Indonesians with type 2 diabetes
TL;DR: Indonesian subjects with DM2 had more prevalent and more severeperiodontitis than healthy Indonesian subjects, independent of confounding factors or the methods used to operationalize periodontitis.
Journal ArticleDOI
Five-year follow-up of oral functioning and quality of life in patients with oral cancer with implant-retained mandibular overdentures.
Anke Korfage,Pieter Schoen,Gerry M. Raghoebar,Jelte Bouma,Fred R. Burlage,Jan L. N. Roodenburg,Arjan Vissink,Harry Reintsema +7 more
TL;DR: The purpose of this prospective study was to assess the quality of life and oral functioning of patients with oral cancer up to 5 years after prosthodontic rehabilitation with mandibular implant‐retained overdentures.
Journal ArticleDOI
Use of cultured mucosal grafts to cover defects caused by vestibuloplasty - an in-vivo study
Gerry M. Raghoebar,Anna M Tomson,Janny Scholma,Engbert H Blaauw,Max J. H. Witjes,Arjan Vissink +5 more
TL;DR: It was concluded that cultured mucosa can serve as a proper dressing for mucosal defects after vestibuloplasty and formed a fully differentiated keratinizing mucosa with a well-developed basement membrane and rete ridges, comparable with the histology and ultrastructure of palatal mucosa in situ.
Journal ArticleDOI
Abatacept treatment for patients with early active primary Sjogren's syndrome : a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
Jolien F van Nimwegen,Esther Mossel,Greetje S. van Zuiden,Robin F. Wijnsma,Konstantina Delli,Alja J Stel,Bert van der Vegt,Erlin A. Haacke,Lisette Olie,Leonoor I. Los,Gwenny M Verstappen,Sarah Pringle,Fred K L Spijkervet,Frans G. M. Kroese,Arjan Vissink,Suzanne Arends,Hendrika Bootsma +16 more
TL;DR: This trial cannot recommend abatacept treatment as standard of care to reduce systemic disease activity in patients with primary Sjogren's syndrome, and further studies should evaluate whether patients with specific clinical manifestations and biological characteristics might benefit from abatACEpt treatment.
Journal ArticleDOI
Morbidity of chin bone transplants used for reconstructing alveolar defects in cleft patients
TL;DR: It was showed that chin bone harvesting for reconstructing alveolar cleft in young patients is a well-accepted procedure with low objective and subjective morbidity and the patients (and their parents) have to be informed about the risk of subjective and objective disturbances of the sensibility in the donor region and therisk of dental pulp necrosis.